Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Puji Biotechnology is a Shanghai-based molecular diagnostics company specializing in rapid, point-of-care testing (POCT) solutions for infectious diseases. The company leverages its proprietary microfluidic and isothermal amplification technologies to develop integrated sample-to-answer diagnostic platforms. Their flagship i-Reader system provides lab-quality molecular results in decentralized settings in under 30 minutes. Puji's product portfolio includes assays for respiratory, gastrointestinal, and sexually transmitted infections, as well as specialized kits for SARS-CoV-2. By simplifying complex molecular workflows, the company aims to improve patient outcomes through timely and accurate diagnosis at the point of care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Puji Biotechnology.